REG - South32 Limited - Director/PDMR Shareholding

South32Announcement

08/04/2019 08:55

RNS Number : 4162V
South32 Limited
08 April 2019
 


Notification of dealing form



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Dr Ntombifuthi Mtoba




2


Reason for the notification  




a)


Position/status


Non-Executive Director




b)


Initial notification/Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  




a)


Name


South32 Limited




b)


LEI


213800LAZNPXSBKVHR17




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
 Identification code


Ordinary shares
AU000000S320




b)


Nature of the transaction


On-market purchase of South32 Limited ordinary shares on the Johannesburg Stock Exchange.




c)


Price(s) and volume(s)





Price(s)


Volume(s)




ZAR         39.17
ZAR         39.18
ZAR         39.16
ZAR         39.17
ZAR         39.17
ZAR         39.15
ZAR         39.16
ZAR         39.14
ZAR         39.14


1717
1872
950
1703
1832
600
2500
1807
2500
 








d)


Aggregated information
- Aggregated volume
- Price









Price


Volume


Total




39.17


1717


67,254.89




39.18


1872


73,344.96




39.16


950


37,202.00




39.17


1703


66,706.51




39.17


1832


71,759.44




39.15


600


23,490.00




39.16


2500


97,900.00




39.14


1807


70,725.98




39.14


2500


97,850.00


















Aggregated


39.16


15,481


606,233.78








e)


Date of the transaction


3 April 2019




f)


Place of the transaction


XJSE



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUWVBRKUASRRR